0000899243-21-025140.txt : 20210621 0000899243-21-025140.hdr.sgml : 20210621 20210621202242 ACCESSION NUMBER: 0000899243-21-025140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210617 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Hauwermeiren Timothy CENTRAL INDEX KEY: 0001816206 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 211032694 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-17 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816206 Van Hauwermeiren Timothy C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 26.03 2021-06-17 4 A 0 16608 0.00 A 2031-06-17 Common Stock 16608 0 D This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders. /s/ Michel Detheux, as Attorney-in-Fact 2021-06-21